✦ LIBER ✦

The DNA tumor virus SV 40 induces gene mutations in human cells. Reversion of HPRT deficiency

✍ Scribed by Lieselotte Lübbe; Michael Strauss; Siegfried Scherneck; Erhard Geissler

Publisher: Springer
Year: 1982
Tongue: English
Weight: 508 KB
Volume: 61
Category: Article
ISSN: 0340-6717
DOI: 10.1007/bf00296449

No coin nor oath required. For personal study only.

✦ Synopsis

The mutagenic effect of papovavirus SV40 on human cells could be demonstrated by reversion of HPRT deficiency in Lesch-Nyhan fibroblasts transformed by the virus. SV40 seems to induce different gene mutations in individually selected cell clones, as was clearly shown by the respective HPRT enzyme properties. The consequences of our results for use of SV40-derived vectors in gene substitution experiments are discussed.

📜 SIMILAR VOLUMES

Nitric oxide–induced mutations in the HP

Nitric oxide–induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium

✍ John C. Zhuang; Teresa L. Wright; Teresa deRojas-Walker; Steven R. Tannenbaum; G 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

Characterization of mutations induced by NO in different experimental systems will facilitate elucidation of mechanisms underlying its genotoxicity. The mutagenic specificity of NO in human cells is of particular interest in view of its potential role in inflammation-associated carcinogenesis. We co

Differences in the capacity of simian vi

Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice

✍ Lloyd W. Law; Kenneth K. Takemoto; Michael J. Rogers; Ole Henriksen; Robert C. T 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 French ⚖ 715 KB

## Abstract The immunogenicity of the SV40 tumor‐specific transplantation antigen (TSTA) on cells, cell particulates and solubilized membranes was studied in mice and in Syrian hamsters. Immunizations were done with various concentrations of tissue‐culture‐passaged, non‐virus‐releasing transformed